$9.16
2.14% today
Nasdaq, Apr 03, 06:45 pm CET
ISIN
US15102K1007
Symbol
CELC

Celcuity Inc. Stock price

$9.36
+0.46 5.17% 1M
-5.31 36.20% 6M
-3.73 28.50% YTD
-10.28 52.34% 1Y
-0.75 7.42% 3Y
+4.01 74.95% 5Y
-4.93 34.50% 10Y
Nasdaq, Closing price Wed, Apr 02 2025
+0.07 0.75%
ISIN
US15102K1007
Symbol
CELC
Sector
Industry

Key metrics

Market capitalization $354.18m
Enterprise Value $217.03m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio 3.01
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-113.27m
Free Cash Flow (TTM) Free Cash Flow $-83.72m
Cash position $235.10m
EPS (TTM) EPS $-2.81
P/E forward negative
Short interest 10.01%
Show more

Is Celcuity Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Celcuity Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Celcuity Inc. forecast:

8x Buy
100%

Analyst Opinions

8 Analysts have issued a Celcuity Inc. forecast:

Buy
100%

Financial data from Celcuity Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
- -
-
100%
- Direct Costs 0.13 0.13
7% 7%
-
-0.13 -0.13
7% 7%
-
- Selling and Administrative Expenses 8.80 8.80
64% 64%
-
- Research and Development Expense 104 104
72% 72%
-
-113 -113
71% 71%
-
- Depreciation and Amortization 0.13 0.13
7% 7%
-
EBIT (Operating Income) EBIT -113 -113
71% 71%
-
Net Profit -112 -112
75% 75%
-

In millions USD.

Don't miss a Thing! We will send you all news about Celcuity Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Celcuity Inc. Stock News

Neutral
GlobeNewsWire
2 days ago
MINNEAPOLIS, April 01, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that Brian Sullivan, Chief Executive Officer, and Co-founder of Celcuity, will present and be available for one-on-one investor meetings at the following investor conferences:
Neutral
Seeking Alpha
3 days ago
Celcuity Inc. (NASDAQ:CELC ) Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ET Company Participants Apoorva Chaloori - ICR Healthcare, Investor Relations Brian Sullivan - Co-Founder & Chief Executive Officer Vicky Hahne - Chief Financial Officer Conference Call Participants Maury Raycroft - Jefferies Brad Canino - Stifel Oliver McCammon - LifeSci Capital Gil Blum - Needham Corporation ...
Neutral
GlobeNewsWire
3 days ago
MINNEAPOLIS, March 31, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced financial results for the fourth quarter ended December 31, 2024 and other recent business developments.
More Celcuity Inc. News

Company Profile

Celcuity, Inc. is cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. Its proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Head office United States
CEO Brian Sullivan
Employees 87
Founded 2012
Website www.celcuity.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today